COMPANY PROFILE

CoreMap

Explore full profile

Improving patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients

Burlington, United StatesFounded 2016Health Tech & Medtech

Valuation $100–250M Last recorded · 2026

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About CoreMap

CoreMap is a medical technology company specializing in advanced diagnostic solutions for atrial fibrillation (AF), a common heart arrhythmia. Founded in 2016 and headquartered in Vermont and Massachusetts, CoreMap aims to revolutionize the treatment of AF by providing physicians with high-resolution mapping tools that enable patient-specific treatments. The company's investigational devices are designed to offer precise diagnostics, which can lead to more effective and individualized treatment plans for patients suffering from persistent and complex atrial arrhythmias. CoreMap primarily serves healthcare providers and cardiologists who treat AF patients, operating within the medical technology and healthcare sectors. The business model focuses on the development and commercialization of its proprietary diagnostic technology, generating revenue through the sale and licensing of its devices.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Burlington, United States
Employees: 44
Open positions: 8
Dealroom signal: 80.0/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Medical & Healthcare, Health Diagnostics, Spinout, Diagnosis and Monitoring, DT and LS, science-based
Technology: Deep Tech
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Jul 2026	$37M	$148M	Medtronic	↗
SERIES BOther financing	Feb 2022	$20M	$80M	Russ Scully · Qure Ventures	↗

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

CoreMap website traffic

Latest recorded traffic for CoreMap is 1.7K monthly website visits, down 43.3% over the last three months. CoreMap's team grew 12.8% over the past year.

Latest monthly visits1.7K 3-month web change-43.3% 1-year team growth+12.8%

Monthly website visitsOct 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Senior Systems EngineerBurlington, Massachusetts, United States, Northern America, Americas · Backend Development · Jul 29, 2026 Senior System EngineerBurlington, MA · Backend Development · Jul 28, 2026 Mixed Python / C++ Software Engineering ManagerCambridge Street, Burlington, Middlesex County, Massachusetts, 01803, United States · Backend Development · Jul 22, 2026 Clinical Mapping SpecialistCambridge Street, Burlington, Middlesex County, Massachusetts, 01803, United States · Data Science & Engineering · Jul 18, 2026 Production Operations AssociateBurlington, MA · Project Management · Jul 2, 2026

5 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PRProAxsisSpecialising in assay development for the capture, detection and measurement of active protease biomarkers of diseases	Belfast, United Kingdom	Operational	7	$3.8M	$1.3M
DIDigeHealthNon invasive bowel monitoring for early detection and prevention	Epalinges, Switzerland	Operational
LULumetallixOffers a spray‑on reagent and UV light that instantly reveals lead by causing it to glow bright green	Amsterdam, Netherlands	Operational
AMAtrian MedicalRestoring Rhythm through Science	Galway, Ireland	Operational
NANIRAMAI Health AnalytixNIRAMAI has developed a novel breast cancer screening solution that uses Thermalytix	Bengaluru, India	Operational
SBShuwen BiotechEngaged in licensing, developing and distributing innovative products and services for disease diagnosis and personalized medicine	Hangzhou, China	Operational
ALAlleSenseDeveloping the NanoMslide, a coated microscope slide that enables label-free, colour-enhanced imaging	Melbourne, Australia	Operational
VIVitalSignsAI-powered multimodal device for streamlined diagnostic biosignal analysis	Espoo, Finland	Operational